Search

Strober, Bruce, Caitriona Ryan, Peter van de Kerkhof, Joelle van der Walt, Alexa B Kimball, Jonathan Barker, Andrew Blauvelt, and International Psoriasis Council Board Members and Councilors. 2020. “Recategorization of Psoriasis Severity: Delphi Consensus from the International Psoriasis Council.”. Journal of the American Academy of Dermatology 82 (1): 117-22.

Reich, K, K A Papp, A W Armstrong, Y Wasfi, S Li, Y K Shen, B Randazzo, M Song, and A B Kimball. 2019. “Safety of Guselkumab in Patients With Moderate-to-Severe Psoriasis Treated through 100 Weeks: A Pooled Analysis from the Randomized VOYAGE 1 and VOYAGE 2 Studies.”. The British Journal of Dermatology 180 (5): 1039-49.

Strober, Bruce E, Joelle M van der Walt, April W Armstrong, Marc Bourcier, Andre E Carvalho V, Edgardo Chouela, Arnon D Cohen, et al. 2019. “Clinical Goals and Barriers to Effective Psoriasis Care.”. Dermatology and Therapy 9 (1): 5-18.

Langley, R G, A B Kimball, H Nak, W Xu, B Pangallo, O O Osuntokun, N Agada, and K Reich. 2019. “Long-Term Safety Profile of Ixekizumab in Patients With Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis from 11 Clinical Trials.”. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (2): 333-39.

Blauvelt, A, K Reich, K A Papp, A B Kimball, M Gooderham, S K Tyring, R Sinclair, et al. 2018. “Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Three Randomized Controlled Trials.”. The British Journal of Dermatology 179 (3): 615-22.

Golbari, Nicole M, Martina L Porter, and Alexa B Kimball. 2018. “Discordance Between Patient Reported Motivations to Seek Treatment for Psoriasis Compared to Television Advertisements.”. Journal of Drugs in Dermatology : JDD 17 (8): 886-87.

Snyder, Corey L, Ruby S Gibson, Martina L Porter, and Alexa B Kimball. 2023. “Secukinumab in the Treatment of Hidradenitis Suppurativa.”. Immunotherapy 15 (17): 1449-57.

Garg, Amit, Yvonne Geissbühler, Emma Houchen, Nilesh Choudhary, Disha Arora, Varun Vellanki, Abhishek Srivastava, et al. 2023. “Disease Burden and Treatment Patterns Among US Patients With Hidradenitis Suppurativa: A Retrospective Cohort Study.”. American Journal of Clinical Dermatology 24 (6): 977-90.

Garg, Amit, Haley B Naik, Afsaneh Alavi, Paul Hazen, Jennifer L Hsiao, Vivian Y Shi, Jamie Weisman, et al. 2023. “Real-World Findings on the Characteristics and Treatment Exposures of Patients With Hidradenitis Suppurativa from US Claims Data.”. Dermatology and Therapy 13 (2): 581-94.

Gibson, Ruby S, Martina L Porter, and Alexa B Kimball. 2022. “Erythrocyte Sedimentation Rate, Rather Than C-Reactive Protein, May Be the Preferred Biomarker for Hidradenitis Suppurativa.”. JAAD International 8: 47-48.